Nolato is an international public company based in Sweden, with a strong heritage dating back to 1938. Listed on NASDAQ for over 40 years, Nolato generates approximately €1 billion in annual revenue and operates around 30 sites across ten countries, primarily focused on life sciences and medical industries. The company's operations are divided into four key areas: pharmaceutical packaging, drug delivery systems, medical devices, and diagnostics.

Nolato specializes in supporting its partners throughout the entire product development lifecycle, from initial concept to high-volume manufacturing. Their integrated approach incorporates modern design for manufacturing (DfM) services, utilizing advanced tools like virtual prototyping to streamline the design process and identify potential issues early on. This commitment to robust design methods extends to eco-design principles, focusing on sustainability while maintaining cost competitiveness. By leveraging their decentralized structure and engaging local site expertise, Nolato ensures that every project meets customer-specific needs and regulatory standards, facilitating a smooth transition to scalable production.